ArticleBMC cancer2025

EZH2 confers lenvatinib resistance in hepatocellular carcinoma by suppressing ACSL1-Mediated ferroptosis.

Yibin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.